These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10348370)

  • 41. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.
    Lowell GH; Kaminski RW; Grate S; Hunt RE; Charney C; Zimmer S; Colleton C
    Infect Immun; 1996 May; 64(5):1706-13. PubMed ID: 8613381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
    Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
    Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of protective immunity in mice induced by drug-attenuated larvae of Schistosoma mansoni. Antigen localization and antibody responses.
    Mountford AP; Coulson PS; Saunders N; Wilson RA
    J Immunol; 1989 Aug; 143(3):989-95. PubMed ID: 2501388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin.
    Flanigan TP; King CH; Lett RR; Nanduri J; Mahmoud AA
    J Clin Invest; 1989 Mar; 83(3):1010-4. PubMed ID: 2493482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of Sm20.8, a member of a family of schistosome tegumental antigens.
    Mohamed MM; Shalaby KA; LoVerde PT; Karim AM
    Mol Biochem Parasitol; 1998 Oct; 96(1-2):15-25. PubMed ID: 9851603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of protective immunity and modulation of granulomatous hypersensitivity in mice using PIII, an anionic fraction of Schistosoma mansoni adult worm.
    Hirsch C; Zouain CS; Alves JB; Goes AM
    Parasitology; 1997 Jul; 115 ( Pt 1)():21-8. PubMed ID: 9280892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.
    El Ridi R; Tallima H; Mahana N; Dalton JP
    Microbes Infect; 2010 Sep; 12(10):700-9. PubMed ID: 20452455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni.
    Ranasinghe SL; Duke M; Harvie M; McManus DP
    Int J Infect Dis; 2018 Jan; 66():26-32. PubMed ID: 29128645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sm480: a high molecular weight Schistosoma mansoni antigen associated with protective immunity.
    Curtis RH; Fallon PG; Doenhoff MJ
    Parasite Immunol; 1996 Mar; 18(3):149-57. PubMed ID: 9223169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the protective resistance induced by 60Co-irradiated cercariae and schistosomula of the WFFS and NMRI strains of Schistosoma mansoni.
    James ER; Dobinson AR
    J Helminthol; 1985 Dec; 59(4):313-7. PubMed ID: 3937852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surface antigens of and cross-protection between two geographical isolates of Schistosoma mansoni.
    Hackett F; Simpson AJ; Omer-Ali P; Smithers SR
    Parasitology; 1987 Apr; 94 ( Pt 2)():301-12. PubMed ID: 3108832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects.
    James SL; DeBlois LA
    J Immunol; 1986 May; 136(10):3864-71. PubMed ID: 3084645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Protective Role of Toll-Like Receptor Agonist Monophosphoryl Lipid A Against Vaccinated Murine Schistosomiasis.
    Aly I; Ibrahim EH; Hamad RS; Sayed HEL; Attiyah SMN; E-Komy W; Ghramh HA; Alshehri A; Alsyaad KM; Alshehri M; Kilany M; Morsy K; El-Kott AF; Taha R
    Acta Parasitol; 2020 Sep; 65(3):652-660. PubMed ID: 32240492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of protective immunity of 28KD-GST as a vaccine against experimental Schistosoma mansoni.
    Hassan MM; Moustafa NE; El-Motayam MH; El-Settawy MA; Taha AA
    J Egypt Soc Parasitol; 2009 Aug; 39(2):403-12. PubMed ID: 19795747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Schistosoma mansoni: anomalous immunogenic properties of a 27 kDa larval serine protease associated with protective immunity.
    Darani HY; Curtis RH; McNeice C; Price HP; Sayers JR; Doenhoff MJ
    Parasitology; 1997 Sep; 115 ( Pt 3)():237-47. PubMed ID: 9300461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant.
    Mountford AP; Anderson S; Wilson RA
    J Immunol; 1996 Jun; 156(12):4739-45. PubMed ID: 8648120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reevaluation of the potential of Fasciola hepatica antigens for immunization against Schistosoma mansoni infection.
    Ford MJ; Taylor MG; Bickle QD
    Parasitology; 1987 Apr; 94 ( Pt 2)():327-36. PubMed ID: 3108833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.